NCT07025421 The ARISE Study - Use of Vertical Positioning
| NCT ID | NCT07025421 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alabama at Birmingham |
| Condition | Acute Respiratory Distress Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-08-25 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-08-25 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The pilot study will randomize 40 ARDS patients who if proning were required would be randomized to upright bed positioning or to stand of care with bed in the head of bed elevation position
Eligibility Criteria
Inclusion Criteria: \- Acute Respiratory Distress Syndrome Exclusion Criteria: * Cancer * Active tracheostomy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07025421 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Acute Respiratory Distress Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07025421 currently recruiting?
Yes, NCT07025421 is actively recruiting participants. Contact the research team at pmorris@uabmc.edu for enrollment information.
Where is the NCT07025421 trial being conducted?
This trial is being conducted at Birmingham, United States.
Who is sponsoring the NCT07025421 clinical trial?
NCT07025421 is sponsored by University of Alabama at Birmingham. The trial plans to enroll 40 participants.